Research Analysts’ Updated EPS Estimates for September 24th (AARD, ABCL, ACAD, ALKT, ALM, ARE, ARWR, AUR, BKNG, BP)

Research Analysts’ updated eps estimates for Thursday, September 24th:

Aardvark Therapeutics (NASDAQ:AARD) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $6.00 price target on the stock.

AbCellera Biologics (NASDAQ:ABCL) had its neutral rating reissued by analysts at The Goldman Sachs Group, Inc.. They currently have a $13.00 price target on the stock.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $41.00 target price on the stock.

Alkami Technology (NASDAQ:ALKT) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $14.00 target price on the stock, down from their previous target price of $24.00.

Alkami Technology (NASDAQ:ALKT) had its market outperform rating reiterated by analysts at Citizens Jmp. The firm currently has a $24.00 price target on the stock.

The Goldman Sachs Group, Inc. initiated coverage on shares of Almonty Industries (NASDAQ:ALM). The Goldman Sachs Group, Inc. issued a neutral rating and a $13.00 price target on the stock.

Alexandria Real Estate Equities (NYSE:ARE) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $56.00 price target on the stock.

The Goldman Sachs Group, Inc. started coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR). The Goldman Sachs Group, Inc. issued a neutral rating and a $74.00 price target on the stock.

Aurora Innovation (NASDAQ:AUR) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $13.00 price target on the stock.

Booking (NASDAQ:BKNG) had its buy rating reissued by analysts at BTIG Research. They currently have a $250.00 price target on the stock.

BP (LON:BP) had its buy rating reissued by analysts at Royal Bank Of Canada.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at UBS Group AG.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reaffirmed by analysts at Bank of America Corporation.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft.

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reissued by analysts at JPMorgan Chase & Co..

Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc..

Citizens Jmp initiated coverage on shares of BlueLinx (NYSE:BXC). The firm issued a market perform rating on the stock.

Cintas (NASDAQ:CTAS) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $206.00 target price on the stock.

CVS Group (LON:CVSG) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 2,000 price target on the stock.

CVS Group (LON:CVSG) had its hold rating reiterated by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 1,400 target price on the stock.

DFS Furniture (LON:DFS) had its buy rating reissued by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 180 target price on the stock.

Darden Restaurants (NYSE:DRI) had its hold rating reissued by analysts at TD Cowen. The firm currently has a $215.00 price target on the stock.

Dycom Industries (NYSE:DY) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $476.00 target price on the stock.

Empire Metals (LON:EEE) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 62 target price on the stock.

Wedbush began coverage on shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX). Wedbush issued an outperform rating and a $17.00 target price on the stock.

Barclays PLC assumed coverage on shares of FuelCell Energy (NASDAQ:FCEL). The firm issued an equal weight rating and a $20.00 price target on the stock.

Fervo Energy (NASDAQ:FRVO) had its outperform rating reiterated by analysts at Sanford C. Bernstein. Sanford C. Bernstein currently has a $47.00 target price on the stock.

Gaming and Leisure Properties (NASDAQ:GLPI) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $46.00 target price on the stock.

Getty Realty (NYSE:GTY) had its overweight rating reiterated by analysts at KeyCorp. KeyCorp currently has a $36.00 target price on the stock.

Intel (NASDAQ:INTC) had its hold rating reaffirmed by analysts at TD Cowen. They currently have a $115.00 price target on the stock.

Ionis Pharmaceuticals (NASDAQ:IONS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $100.00 price target on the stock.

International Paper (NYSE:IP) had its buy rating reissued by analysts at Argus. The firm currently has a $45.00 price target on the stock.

JD Sports Fashion (LON:JD) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 150 price target on the stock.

Kraft Heinz (NASDAQ:KHC) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $32.00 price target on the stock.

Kite Realty Group Trust (NYSE:KRG) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. The firm currently has $27.00 target price on the stock.

Ligand Pharmaceuticals (NASDAQ:LGND) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $358.00 price target on the stock.

Lowe’s Companies (NYSE:LOW) was downgraded by analysts at Gordon Haskett from a buy rating to a hold rating. Gordon Haskett currently has $200.00 price target on the stock.

Maze Therapeutics (NASDAQ:MAZE) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $110.00 price target on the stock.

Mercia Asset Management (LON:MERC) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 67 target price on the stock.

Meta Platforms (NASDAQ:META) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $770.00 target price on the stock.

Bank of America Corporation started coverage on shares of MGE Energy (NASDAQ:MGEE). They issued a neutral rating and a $76.00 target price on the stock.

Bank of America Corporation started coverage on shares of MGM Resorts International (NYSE:MGM). The firm issued a neutral rating and a $40.00 price target on the stock.

Truist Financial Corporation assumed coverage on shares of MiniMed Group (NASDAQ:MMED). The firm issued a buy rating and a $29.00 price target on the stock.

Micron Technology (NASDAQ:MU) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $1,500.00 price target on the stock.

NeoVolta (NASDAQ:NEOV) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $8.00 target price on the stock.

Nuvectis Pharma (NASDAQ:NVCT) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $39.00 target price on the stock.

NWF Group (LON:NWF) had its hold rating reaffirmed by analysts at Shore Capital Group Ltd. They currently have a GBX 150 price target on the stock.

Okta (NASDAQ:OKTA) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $219.00 target price on the stock.

Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $120.00 price target on the stock.

Oruka Therapeutics (NASDAQ:ORKA) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $165.00 price target on the stock.

On the Beach Group (LON:OTB) had its buy rating reissued by analysts at Shore Capital Group Ltd. Shore Capital Group Ltd currently has a GBX 200 price target on the stock.

Everpure (NYSE:P) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $130.00 target price on the stock.

Everpure (NYSE:P) had its buy rating reaffirmed by analysts at Guggenheim. The firm currently has a $150.00 target price on the stock.

Paychex (NASDAQ:PAYX) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $130.00 price target on the stock.

Poolbeg Pharma (LON:POLB) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Permian Resources (NYSE:PR) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $27.00 price target on the stock.

Praxis Precision Medicines (NASDAQ:PRAX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $582.00 price target on the stock.

Prudential (LON:PRU) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 1,445 price target on the stock.

Craig Hallum began coverage on shares of PubMatic (NASDAQ:PUBM). The firm issued a buy rating and a $24.00 price target on the stock.

Rainbow Rare Earths (LON:RBW) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 39 target price on the stock.

Rainbow Rare Earths (LON:RBW) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 52 price target on the stock.

Roku (NASDAQ:ROKU) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $155.00 price target on the stock.

Safehold (NYSE:SAFE) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $14.00 price target on the stock.

Shell (LON:SHEL) had its neutral rating reissued by analysts at Royal Bank Of Canada.

Tanger (NYSE:SKT) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $39.00 price target on the stock.

Spruce Biosciences (NASDAQ:SPRB) had its market outperform rating reiterated by analysts at Citizens Jmp. They currently have a $144.00 price target on the stock.

tinyBuild (LON:TBLD) was downgraded by analysts at Shore Capital Group Ltd to a sell rating. Shore Capital Group Ltd currently has GBX 9 target price on the stock.

Theravance Biopharma (NASDAQ:TBPH) had its neutral rating reissued by analysts at BTIG Research.

LON:TIN (LON:TIN) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 151 price target on the stock.

The Mission Group (LON:TMG) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 55 target price on the stock.

Tesla (NASDAQ:TSLA) had its neutral rating reaffirmed by analysts at UBS Group AG.

Tyler Technologies (NYSE:TYL) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $400.00 target price on the stock.

United Rentals (NYSE:URI) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $1,323.00 target price on the stock.

Americas Gold and Silver (NYSEAMERICAN:USAS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $9.25 target price on the stock.

VICI Properties (NYSE:VICI) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $30.00 target price on the stock.

Yum! Brands (NYSE:YUM) had its hold rating reissued by analysts at Argus.

Zegona Communications (LON:ZEG) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 2,300 price target on the stock.

Receive News & Ratings for Aardvark Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aardvark Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.